Strumento inattivo

Azioni DARA Biosciences Inc Nasdaq

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

DARA BioSciences : Granted Waiver of Product and Establishment Fees by the FDA	08/01/15
DARA BioSciences : Announces Participation at the Aegis Capital Corporation Healthcare and Technology Conference in Las Vegas	16/09/14
DARA BioSciences : Announces New Retail Patient Savings Program to Support Market Demand for DARA's Flagship Oncology Products	11/05/14
DARA BioSciences : Announces Addition of Soltamox(R), (Tamoxifen Citrate) Oral Solution, to the Authorized Federal Supply Schedule Price List	11/05/14

Settore

	Variaz. 1 gen.	Capi.
MERCK KGAA	+6,42%	70,2 Mrd
KYOWA KIRIN CO. LTD.	+30,84%	10,12 Mrd
YUHAN CORPORATION	+28,34%	4,83 Mrd
SK BIOPHARMACEUTICALS CO., LTD.	-20,02%	4,53 Mrd
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+18,94%	3,59 Mrd
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+22,06%	2,18 Mrd
BETTA PHARMACEUTICALS CO., LTD.	-36,80%	1,8 Mrd
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-42,53%	1,74 Mrd
VELOXIS PHARMACEUTICALS A/S	-0,50%	1,64 Mrd